Instead, we found that the simultaneous inhibition of CCR1 and CCR5 prevents MDSC differentiation driven by tumor derived factors or recombinant cytokines and promotes the generation of neutrophils with a strong antitumor activity. The gene discussed is CCR5; the disease is neoplasm.